Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Novogen Ltd.

www.novogen.com

Latest From CStone Pharmaceuticals Co. Ltd.

Now What? Sanofi CEO Urges Incentives As China Embraces New Drugs

Delinking drug approvals from price agreements, and providing timely and adequate reimbursement coverage, are just some of the policy changes top big pharma executives would like to see if China is to create an operating environment conducive to innovation.

China Policy

Early Stage Biopharma Financings Kept Up Multibillion-Dollar Pace In 2016

Series A venture capital and seed funding rounds for biopharma firms in 2016 kept pace with the level of investment seen in 2015, excluding one major deal in 2015, laying the foundation for optimism regarding early-stage financings in 2017 for particularly innovative companies.

Financing StartUps and SMEs

Biopharma Quarterly Dealmaking Statistics, Q3 2016

In Q3, biopharma financing totaled $7.4 billion, a large proportion of which was by rare disease developers; among the highlights in the $23 billion in M&As was Allergan's buying spree, including two NASH companies. Just over $20 billion went into biopharma alliance dealmaking, and neurology assets attracted many of the dollars.

BioPharmaceutical Deals

Start-Up Quarterly Statistics, Q3 2016

A review of biopharma start-up dealmaking and financing from July through September 2016, based on data from Strategic Transactions.

StartUps and SMEs Financing
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Therapeutic Areas
  • Cancer
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • Australia
  • Parent & Subsidiaries
  • Novogen Ltd.
  • Senior Management
  • James Garner, MD, CEO
    Cristyn Humphreys, CFO
    David Brown, PhD, CSO
    Peng Leong, PhD, CBO
  • Contact Info
  • Novogen Ltd.
    Phone: (61) 2 9472 4101
    P.O. Box 2333 Hornsby Westfield, NSW 1635
    Australia
Advertisement
Advertisement
UsernamePublicRestriction

Register